What’s New

Latest News

Radiation-Reducing Tech
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
08/18/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex...
08/18/2026
Vascular Disease Management
Vascular Disease Management
A pregnant woman attends her doctor's appointment
News
Untreated Maternal MDD May Outweigh SSRI Risks in Pregnancy
08/18/2026
Brionna Mendoza
Treating MDD during pregnancy should be prioritized as part of maternal and fetal health care, argued the authors of a Special Communication published in JAMA Psychiatry.
Treating MDD during pregnancy should be prioritized as part of maternal and fetal health care, argued the authors of a Special Communication published in JAMA Psychiatry.
Treating MDD during pregnancy...
08/18/2026
Psych Congress Network
Psych Congress Network
News
Third-Generation Anti-CD30 CAR T-Cell Therapy Shows Durable Responses in Relapsed or Refractory CD30-Positive Lymphoma
08/18/2026
Emily Estrada
Results from a phase 1/2 trial showed that third-generation anti-CD30 CAR T-cell therapy produced high response rates and durable disease control in patients with relapsed or refractory CD30-positive lymphoma, with longer survival observed...
Results from a phase 1/2 trial showed that third-generation anti-CD30 CAR T-cell therapy produced high response rates and durable disease control in patients with relapsed or refractory CD30-positive lymphoma, with longer survival observed...
Results from a phase 1/2 trial...
08/18/2026
Oncology
Oncology
News
JAK Inhibitors Demonstrate Improved Efficacy Among Various Skin Conditions
08/18/2026
Rebecca Amrick
A systematic review of clinical trials examining the impact of Janus kinase (JAK) inhibitors on skin conditions found that they demonstrated higher efficacy and comparable safety when compared with a placebo.
A systematic review of clinical trials examining the impact of Janus kinase (JAK) inhibitors on skin conditions found that they demonstrated higher efficacy and comparable safety when compared with a placebo.
A systematic review of clinical...
08/18/2026
First Report Managed Care
First Report Managed Care
News
Racial and Ethnic Disparities in Health Care Experiences Among US Veterans
08/18/2026
Rebecca Amrick
A study found that White veterans were more likely to report positive provider experiences than Black or Hispanic veterans, indicating a persistent gap in care among US veterans.
A study found that White veterans were more likely to report positive provider experiences than Black or Hispanic veterans, indicating a persistent gap in care among US veterans.
A study found that White...
08/18/2026
Veterans Health Today
Veterans Health Today
News
Cytopenia Associated With Worse Survival Outcomes in Patients With Myelofibrosis
08/17/2026
Rebecca Amrick
A study found that the presence of cytopenia was associated with poor survival outcomes in patients with myelofibrosis, suggesting cytopenia as a prognostic marker to monitor during disease management.
A study found that the presence of cytopenia was associated with poor survival outcomes in patients with myelofibrosis, suggesting cytopenia as a prognostic marker to monitor during disease management.
A study found that the presence...
08/17/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
News
Mirabegron Tablets Recalled Due to CGMP Deviations
08/13/2026
Rebecca Amrick
Mirabegron extended-release tablets are under a voluntary Class II recall after an N-nitroso mirabegron impurity was found in the product, violating Current Good Manufacturing Practice specifications.
Mirabegron extended-release tablets are under a voluntary Class II recall after an N-nitroso mirabegron impurity was found in the product, violating Current Good Manufacturing Practice specifications.
Mirabegron extended-release...
08/13/2026
Pharmacy Learning Network
Pharmacy Learning Network

Latest Research

July/August 2026
The Dermatologist
Ultrasound as a Transformative Tool in Dermatology
Vol. 34, Issue 5, Issue August 2026
EMS World Summer 2026 Issue
EMSWorld
Managing Menacing Maternal Mishaps
Vol. 55, Issue 2, Issue August 2026

HMP Global Learning Network

Featured Interviews

Amy paller
Videos
Clinical Management of Atopic Dermatitis Across Childhood
08/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how...
08/01/2026
The Dermatologist
Murugiah_title_slide
Author Interview
Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis — An Interview With Karthik Murugiah, MBBS, MHS
07/31/2026
Karthik Murugiah, MBBS, MHS
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares...
07/31/2026
Journal of Invasive Cardiology
Erin Crown, MHS, PA-C, CAQ-Psychiatry
Clinical Pearls
When to Adjust or Augment Antidepressant Treatment in MDD
07/31/2026
Erin Crown, MHS, PA-C, CAQ
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS,...
07/31/2026
Psych Congress NP Institute
Thumbnail
Videos
How to Implement Subcutaneous Immunotherapy for Providers
07/30/2026
Meagan Farnie, BSN, RN; Pablo Saenz, PharmD; Dean Tuel; Jeff Yorio, MD
The panel outlines how to operationalize subcutaneous immunotherapy in clinical practice, covering efficacy and safety review, insurance and workflow considerations, and strategies for educating patients and care teams during the transition.
The panel outlines how to operationalize subcutaneous immunotherapy in clinical practice, covering efficacy and safety review, insurance and workflow considerations, and strategies for educating patients and care teams during the transition.
The panel outlines how to...
07/30/2026
Oncology
Bruce Sands
Expert Insights
Bruce Sands, MD, on Results from DUET-CD
07/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
07/19/2026
Advances in Inflammatory Bowel Disease Network
Part 5 panel
Videos
Safety Monitoring in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion...
06/24/2026
The Dermatologist
Oncology Learning Network Live Daily
Discussion: CAR-T Cell Therapy Access and Earlier Referral
06/19/2026
Beth Faiman, CNP, PhD; Donna Catamero, ANP-BC, OCN, CCRC
Clinicians discuss key updates in multiple myeloma and plasma cell disorders.
Clinicians discuss key updates in multiple myeloma and plasma cell disorders.
Clinicians discuss key updates...
06/19/2026
Oncology
Pediatric Video Tutorial: The Future of 'Color Coding' Kids
Videos
Pediatric Video Tutorial: The Future of 'Color Coding' Kids
06/19/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
Variations of the Broselow tape have been in use for almost 40 years. Variations of Handtevy have been in use for over 15 years. Let’s use our crystal ball to gaze into the very near future of color coding kids.
Variations of the Broselow tape have been in use for almost 40 years. Variations of Handtevy have been in use for over 15 years. Let’s use our crystal ball to gaze into the very near future of color coding kids.
Variations of the Broselow tape...
06/19/2026
EMSWorld
pediatric asthma
Videos
Pediatric Video Tutorial: Pediatric Asthma
05/19/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
Listening for wheezing is good, but asking two simple questions and listening to them talk can be even better.
Listening for wheezing is good, but asking two simple questions and listening to them talk can be even better.
Listening for wheezing is good,...
05/19/2026
EMSWorld
CTP News Desk Image
Viewpoints
Skin Substitute Reimbursement Changes 2026: MAC Denials, Q Codes, and What’s Next
05/19/2026
Daniel L. Kapp, MD
Daniel Kapp, MD, shares his observations on conflicting Medicare contractor guidance and coding confusion in early 2026 have effectively halting reimbursement for skin substitute applications in one MAC. 
Daniel Kapp, MD, shares his observations on conflicting Medicare contractor guidance and coding confusion in early 2026 have effectively halting reimbursement for skin substitute applications in one MAC. 
Daniel Kapp, MD, shares his...
05/19/2026
Wounds

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use